TRAC
T cell receptor alpha chain constant
Also known as: TRAC_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P01848
- Gene
- TRAC
- Ensembl
- ENSG00000277734
- Chromosome
- 14
- Canonical length
- 140 aa
- Protein class
- Disease related genes, Predicted membrane proteins, T-cell receptor genes
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a nuclear receptor co-repressor that mediates transcriptional silencing of certain target genes. The encoded protein is a member of a family of thyroid hormone- and retinoic acid receptor-associated co-repressors. This protein acts as part of a multisubunit complex which includes histone deacetylases to modify chromatin structure that prevents basal transcriptional activity of target genes. Aberrant expression of this gene is associated with certain cancers. Alternate splicing results in multiple transcript variants encoding different isoforms.[provided by RefSeq, Apr 2011]
Canonical amino-acid sequenceUniProt
140 residues, UniProt reviewed canonical sequence.
>P01848|TRAC
1 IQNPDPAVYQ LRDSKSSDKS VCLFTDFDSQ TNVSQSKDSD VYITDKTVLD MRSMDFKSNS
61 AVAWSNKSDF ACANAFNNSI IPEDTFFPSP ESSCDVKLVE KSFETDTNLN FQNLSVIGFR
121 ILLLKVAGFN LLMTLRLWSSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRAC can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Highest tissue expression
- 734 nTPM
Expression across tissuesHPA
Tissue
- thymus: 734 nTPM
- lymph node: 369 nTPM
- tonsil: 269 nTPM
- appendix: 149 nTPM
- spleen: 126 nTPM
- retina: 105 nTPM
Single-cell type
- t-cells: 482 nCPM
- innate lymphoid cells: 101 nCPM
- rod photoreceptor cells: 59 nCPM
- late primary spermatocytes: 57 nCPM
- epididymal clear cells: 53 nCPM
- nk-cells: 52 nCPM
Immune cell
- T-reg: 4,392 nTPM
- total PBMC: 2,967 nTPM
- memory CD4 T-cell: 2,948 nTPM
- naive CD4 T-cell: 2,681 nTPM
- memory CD8 T-cell: 2,509 nTPM
- naive CD8 T-cell: 2,395 nTPM
Brain region
- basal ganglia: 31 nTPM
- midbrain: 16 nTPM
- cerebellum: 14 nTPM
- amygdala: 11 nTPM
- pons: 7.6 nTPM
- medulla oblongata: 6 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TRAC.
Disease | AllUniProt
Conditions TRAC is implicated in, by any mechanism.
- Immunodeficiency 7 (IMD7) MIM:615387
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 1 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- TCR-alpha-beta-positive T-cell deficiency
Disease | ImmuneIEDB
Conditions an epitope on TRAC was assayed in.
- rheumatoid arthritis B cell
OntologyGO
Biological processes
- adaptive immune response
- alpha-beta T cell activation
- response to bacterium
- T cell receptor signaling pathway
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRAC as an antibody target. Whether an autoantibody or antibody against TRAC could matter depends on whether native TRAC is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRAC is annotated at the cell surface, where native TRAC is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TRAC as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...